BlackRock, Inc. 13D and 13G filings for Veracyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Veracyte, Inc. VCYT |
BLACKROCK INC BLK |
6,558,952 8.400% |
-1,234,107 (-15.84%) |
Filing |
| 2024-07-08 4:32 pm Purchase |
2024-06-30 | 13G | Veracyte, Inc. VCYT |
BLACKROCK INC BLK |
7,793,059 10.200% |
631,193 (+8.81%) |
Filing |
| 2024-01-24 5:23 pm Purchase |
2023-12-31 | 13G | Veracyte, Inc. VCYT |
BLACKROCK INC BLK |
7,161,866 9.800% |
627,297 (+9.60%) |
Filing |
| 2023-01-25 10:36 am Purchase |
2022-12-31 | 13G | Veracyte, Inc. VCYT |
BLACKROCK INC BLK |
6,534,569 9.100% |
261,016 (+4.16%) |
Filing |
| 2022-02-03 4:29 pm Purchase |
2021-12-31 | 13G | Veracyte, Inc. VCYT |
BLACKROCK INC BLK |
6,273,553 8.800% |
992,578 (+18.80%) |
Filing |
| 2021-02-01 08:30 am Purchase |
2020-12-31 | 13G | Veracyte, Inc. VCYT |
BLACKROCK INC BLK |
5,280,975 9.100% |
970,441 (+22.51%) |
Filing |